|
⚲
|
| Keyboard |
| Galson Steven K
✚
|
|
|---|---|
| CIK # | 0001495328 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001495328] | |
| 4 | [0001495328] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Galson Steven K | |
| Biocryst Pharmaceuticals Inc | |
| Vanda Pharmaceuticals Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Biocryst Pharmaceuticals Inc BCRX
Automatic Stock Option Grant · derivative
|
2025-06-12 | Grant | 27,181 | $0.00 | |
|
Biocryst Pharmaceuticals Inc BCRX
Common Stock
|
2025-06-12 | Grant | 12,500 | $0.00 | |
|
Biocryst Pharmaceuticals Inc BCRX
Common Stock
|
2024-06-12 | Grant | 6,820 | $0.00 | |
|
Biocryst Pharmaceuticals Inc BCRX
Automatic Stock Option Grant · derivative
|
2024-06-12 | Grant | 49,933 | $0.00 | |
|
Biocryst Pharmaceuticals Inc BCRX
Common Stock
|
2024-05-13 | Buy | 21,940 | $5.49 | 120,451 |
|
Biocryst Pharmaceuticals Inc BCRX
Automatic Stock Option Grant · derivative
|
2023-06-13 | Grant | 39,072 | $0.00 | |
|
Biocryst Pharmaceuticals Inc BCRX
Common Stock
|
2023-06-13 | Grant | 16,745 | $0.00 | |
|
Biocryst Pharmaceuticals Inc BCRX
Automatic Stock Option Grant · derivative
|
2022-06-07 | Grant | 30,022 | $0.00 | |
|
Biocryst Pharmaceuticals Inc BCRX
Common Stock
|
2022-06-07 | Grant | 12,866 | $0.00 | |
|
Biocryst Pharmaceuticals Inc BCRX
Non-Qualified Stock Option · derivative
|
2021-09-01 | Grant | 60,000 | $0.00 | |
|
Vanda Pharmaceuticals Inc VNDA
Stock Option (Right to Buy) · derivative
|
2014-05-22 | Grant | 15,000 | $0.00 | |
|
Vanda Pharmaceuticals Inc VNDA
Stock Option (Right to Buy) · derivative
|
2013-06-20 | Grant | 15,000 | $0.00 | |
|
Vanda Pharmaceuticals Inc VNDA
Stock Option (Right to Buy) · derivative
|
2012-06-14 | Grant | 15,000 | $0.00 |